Eviive
1 known investors
EVIIVE develops blood-based (liquid biopsy) diagnostics that analyze extracellular vesicle signals between the immune system and tumor environment to predict and guide immunotherapy (IO) treatment response. The diagnostics target precision immunotherapy in oncology, helping identify which cancer patients will respond to first-line IO treatment.
BiotechDeep TechDigital Health
Investors · 1
Frequently asked questions
- What does Eviive do?
- EVIIVE develops blood-based (liquid biopsy) diagnostics that analyze extracellular vesicle signals between the immune system and tumor environment to predict and guide immunotherapy (IO) treatment response. The diagnostics target precision immunotherapy in oncology, helping identify which cancer patients will respond to first-line IO treatment.
- Who are Eviive's investors?
- Eviive's investors include Kickfund.